Table 3 |
||||
|
Subphenotype analysis of rs3738919 in rheumatoid arthritis patients |
||||
|
CC, number (frequency) |
CA, number (frequency) |
AA, number (frequency) |
P value |
|
|
|
||||
|
New Zealand |
||||
|
Gender |
||||
|
Male |
117 (0.500) |
90 (0.385) |
27 (0.115) |
0.026 |
|
Female |
177 (0.394) |
216 (0.481) |
56 (0.125) |
|
|
RF |
||||
|
Yes |
232 (0.431) |
239 (0.444) |
67 (0.125) |
0.75 |
|
No |
49 (0.441) |
51 (0.459) |
11 (0.100) |
|
|
SE |
||||
|
Yes |
241 (0.418) |
269 (0.467) |
66 (0.115) |
0.05 |
|
No |
75 (0.503) |
53 (0.356) |
21 (0.141) |
|
|
Oxford, UK |
||||
|
Gender |
||||
|
Male |
89 (0.434) |
86 (0.420) |
30 (0.146) |
0.55 |
|
Female |
211 (0.416) |
233 (0.460) |
63 (0.124) |
|
|
RF |
||||
|
Yes |
227 (0.411) |
247 (0.447) |
78 (0.141) |
0.34 |
|
No |
69 (0.454) |
68 (0.447) |
15 (0.099) |
|
|
SE |
||||
|
Yes |
226 (0.410) |
254 (0.461) |
71 (0.129) |
0.47 |
|
No |
74 (0.457) |
66 (0.407) |
22 (0.136) |
|
|
WTCCC |
||||
|
Gender |
||||
|
Male |
180 (0.438) |
187 (0.455) |
44 (0.107) |
0.80 |
|
Female |
528 (0.423) |
574 (0.460) |
146 (0.117) |
|
|
|
||||
|
RF, rheumatoid factor; SE, shared epitope; WTCCC, Wellcome Trust Case Control Consortium. |
||||
|
Hollis-Moffatt et al. Arthritis Research & Therapy 2009 11:R152 doi:10.1186/ar2828 |
||||
